Azintuxizumab

Tax included
Azintuxizumab is a monoclonal, B-cell maturation antigen (BCMA)-targeted, IgG4 bispecific antibody. Azintuxizumab has the potential for the research of relapsed/refractory multiple myeloma (RRMM).
MedChemExpress 
HY-P99453

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody
Application
Cancer-programmed cell death
CAS
1826819-57-1